 |
 |
 |
 |
Volume 1, Issue 1, January 2008 |
|
| |
 |
 |
| TABLE OF CONTENTS |
 |
 |
Introduction |
| |
By Jean-Pierre Després, PhD, FAHA, Editor-in-Chief |
page 2 |
| |
|
|
|
Editorial |
| |
By Philippe Pibarot, DVM, PhD, FACC, FAHA, Guest Editor |
pages 3-4 |
| |
|
|
|
Molecular mechanisms of insulin resistance in obesity |
| |
By André Marette, PhD |
pages 5-9 |
| |
|
|
|
The visceral adipocyte and cardiometabolic risk factors |
| |
By André Tchernof, PhD |
pages 10-13 |
| |
|
|
|
Serum insulin and inflammatory markers in overweight people with and without dyslipidemia |
| |
By Philip Barter, MBBS, FRACP, PhD |
pages 14-16 |
| |
|
|
|
Cardiometabolic risk: the surgeon’s perspective |
| |
By Patrick Mathieu, MD Philippe Pibarot, DVM, PhD, FACC, FAHA Jean-Pierre Després, PhD, FAHA |
pages 17-20 |
| |
|
|
|
“Valvulo-metabolic” risk in aortic stenosis |
| |
By Philippe Pibarot, DVM, PhD, FACC, FAHA |
pages 21-25 |
|
 |
 |
 |
|
|
 |
|
